top of page


July 2022 - Present

Founder and Director at Cranmer Consultancy

Freelance health economist, specialising in strategic and technical services, training, value communication, data analysis, economic modelling and literature reviews (see Services).

April 2018 – May 2019

Health Economics Manager

Adapted Global materials for UK HTA and provided input to the Global team throughout development. Drove for UK market access by developing effective health economic strategies and demonstrating value for both pipeline and inline products. Represented Takeda UK & Ireland during the reimbursement process through NICE and SMC.

October 2021 – June 2022

Evidence Generation Manager

Prioritised, strategic recommendations on the evidence requirements for pipeline assets to Global Program Teams, based on patient, payer, prescriber and LOC needs. Shaped clinical development programmes and Global evidence generation plans. Validated and advised on Global access strategy, pricing, and launch scenarios.

October 2016 to April 2018

Senior Health Economist

Developed economic models (including: cost-effectiveness, cost-minimisation and budget-impact) and accompanying technical report/user guide for early data gaps assessment, global needs or HTA purposes. Provided strategic and technical advice to pharmaceutical companies with relation to their HTA strategy. Quality appraisals of economic models/submissions, systematic literature reviews, global value storyboards/dossiers, quality of life studies, survival analysis of time to event (TTE) data, expert elicitation studies and conducting external training sessions.

May 2019 – October 2021

Health Economist Lead

Developed the core Global materials required for HTA, including global economic models (cost-effectiveness, cost-comparison, and budget impact models), systematic literature reviews (clinical and economic), indirect treatment comparisons, statistical analyses (survival analysis, utility analysis and adverse event) and technical reports/user guides. Ensured Global materials were in line with individual country requirements.

June 2013 - October 2016

Health Economist

Economic model development with accompanying technical reports/user guides, contributing to HTA submissions, quality appraisals of economic models/submissions, systematic literature reviews, proposal writing, contribution to global value storyboards/dossiers, utility analysis and mentoring two junior health economists. 

bottom of page